Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) — Strategic Asset Allocation Index
Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Strategic Asset Allocation Index of 65.3% as of June 2023. Strategic assets (PP&E of CN¥2.44 Billion plus long-term investments of CN¥-) total CN¥2.44 Billion, measured against net assets of CN¥3.73 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Strategic Asset Allocation Index (2008–2021)
This chart shows how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2008 to 2021. As of June 2023, the index stands at 65.3%, representing strategic assets of CN¥2.44 Billion against net assets of CN¥3.73 Billion CNY. Explore 300233 cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2021, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 300233 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 60.8% | CN¥2.09 Billion | CN¥2.09 Billion | CN¥- | CN¥3.44 Billion | ▲ +9.6 pp |
| 2020 | 51.3% | CN¥1.78 Billion | CN¥1.78 Billion | CN¥- | CN¥3.47 Billion | ▲ +9.6 pp |
| 2019 | 41.7% | CN¥1.70 Billion | CN¥1.70 Billion | CN¥- | CN¥4.08 Billion | ▲ +2.2 pp |
| 2018 | 39.5% | CN¥1.61 Billion | CN¥1.50 Billion | CN¥117.33 Million | CN¥4.09 Billion | ▲ +4.3 pp |
| 2017 | 35.2% | CN¥1.39 Billion | CN¥1.33 Billion | CN¥60.96 Million | CN¥3.94 Billion | ▼ -24.7 pp |
| 2016 | 59.9% | CN¥900.61 Million | CN¥843.31 Million | CN¥57.30 Million | CN¥1.50 Billion | ▲ +0.2 pp |
| 2015 | 59.7% | CN¥781.91 Million | CN¥774.61 Million | CN¥7.30 Million | CN¥1.31 Billion | ▼ -8.9 pp |
| 2014 | 68.6% | CN¥766.02 Million | CN¥766.02 Million | CN¥- | CN¥1.12 Billion | ▼ -3.4 pp |
| 2013 | 72.0% | CN¥735.76 Million | CN¥735.76 Million | CN¥- | CN¥1.02 Billion | ▲ +10.4 pp |
| 2012 | 61.6% | CN¥600.89 Million | CN¥600.89 Million | CN¥- | CN¥975.57 Million | ▲ +4.0 pp |
| 2011 | 57.6% | CN¥552.04 Million | CN¥552.04 Million | CN¥- | CN¥958.84 Million | ▼ -64.9 pp |
| 2010 | 122.5% | CN¥459.85 Million | CN¥459.85 Million | CN¥- | CN¥375.33 Million | ▲ +6.2 pp |
| 2009 | 116.3% | CN¥327.50 Million | CN¥327.50 Million | CN¥- | CN¥281.53 Million | ▲ +26.5 pp |
| 2008 | 89.8% | CN¥194.41 Million | CN¥194.41 Million | CN¥- | CN¥216.49 Million | — |